<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Skybiotech Healthcare Limited has submitted a confirmation to BSE stating that it does not fall under the category of 'Large Corporate' as defined under SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018. The company clarified that as of March 31st, 2026, it does not meet the applicability criteria for large entities required to make disclosures related to fund raising through issuance of debt securities. This is a routine compliance filing where the company confirms it is not subject to the additional SEBI disclosure and compliance requirements applicable to large corporates.
Neutral impact for shareholders. The company avoids additional regulatory compliance burdens associated with large corporate status, which typically applies to entities with higher debt mobilization. This confirmation indicates Skybiotech remains a smaller entity without mandatory debt-related disclosure obligations to SEBI.